Get started

Jaguarhealth

JAXG, a lowkey health stock with multi bagger growth prospect!After skimming on low cap stocks which have huge growth potential but have been on signficant correction, I came across JAGX, a pharmaceutical company focused on developing plant-based, non-opioid, and sustainably derived prescription medicines. Weekly data is showing weakening of sellers. An accumulation / net buying at the current price range has been spotted. Volume have increased from 1.73M to 2.22M. Again, its a low cap -- and the catch with low cap stocks is liquidity. Be mindful on that aspect. Spotted at 0.6090 TAYOR.
NASDAQ:JAGXLong
by JSAL
JAGX | Close to a Bottom? | BounceJaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The company also develops Crofelemer for multiple possible follow-on indications, including cancer therapy-related diarrhea; orphan-drug indications for symptomatic relief of diarrhea in infants and children with congenital diarrheal disorders and for adult and pediatric patients for short bowel syndrome with intestinal failure with; supportive care for diarrhea relief in inflammatory bowel diseases; diarrhea-predominant irritable bowel syndrome; and for idiopathic/functional diarrhea. In addition, it develops lechlemer, a second-generation anti-secretory agent for cholera; and Canalevia, an oral plant-based drug candidate to treat chemotherapy-induced diarrhea in dogs and exercise-induced diarrhea in dogs. Jaguar Health, Inc. was founded in 2013 and is headquartered in San Francisco, California.
NASDAQ:JAGXLong
by DivergenceSeeker
5
#JAGX Price breaking wedge at apex level with huge volumes!🔥GO!Hi All, my main 3 take-outs from this analysis are the following: 1- Price brke the descending wedge at apical level with huge volumes. The movement was quite predictable as the prices were compressing more and more at the apex 2- My long term targets stays at around 6$-7$, as result of the wedge height projection and the breakout point 3- RSI indicating momentum approaching 50 level and pointing upward. Retracements are possible, but in the long term I am strongly bullish on Jaguar Not a financial advice, just personal opinion. Do your own due diligence and good luck!
NASDAQ:JAGXLong
by FrancescoMerlettini
JAGX Would you buy something that was 10000x more expensive? Jaguar Health, Inc. is a commercial stage natural-products pharmaceuticals company, focuses on developing gastrointestinal products for human prescription use and animals worldwide. July 20, 2020 : Jaguar Health, Inc. announced today that it has submitted to the U.S. Food and Drug Administration's Center for Veterinary Medicine the second-to-last required technical section to support approval of Jaguar's oral plant-based drug candidate Canalevia™ (crofelemer delayed-release tablets) to treat chemotherapy-induced diarrhea in dogs, although this filing was originally scheduled for submission by the end of August 2020. More than 230,000 dogs in the U.S. receive chemotherapy treatment for various cancers each year, and roughly one in four (more than 50,000 dogs) will experience diarrhea as a side effect of treatment. OASIS CAPITAL LLC REPORTS 9.99% PASSIVE STAKE IN JAGUAR HEALTH AS OF JULY 7- SEC FILING Net Income $-38,540,000 Market Cap $42.15 million Annual Sales $5.78 million Debt-to-Equity Ratio 0.08 JAGX is a risky bet that can double your money in seconds. Not trading advice. If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
NASDAQ:JAGXLong
by TopgOptions
5